Compositions and methods of treating abnormal cell proliferation
CA 2337138 A1 · Owner: Gentrix Llc · Inventors: Achkar, Charles C.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A composition is described comprising a vitamin D analog and a retinoid wherein: (a) the vitamin D analog is capable of binding a vitamin D receptor or being converted in vivo into a compound capable of binding a vitamin D receptor; and (b) the retinoid is selected from the group consisting of retinol in a concentration of at least about 1.0 % a compound in a , concentration of at least about 1.0 % capable of being converted in vivo into retinol, and a retinoid characterized by having a substitution at the 4position. Further, methods of treating disorders characterized by abnormal cell-proliferation and/or cell-differentiation are also described.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 13, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 13, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 13, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.